POST THROMBOTIC SYNDROME
Clinical trials for POST THROMBOTIC SYNDROME explained in plain language.
Never miss a new study
Get alerted when new POST THROMBOTIC SYNDROME trials appear
Sign up with your email to follow new studies for POST THROMBOTIC SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cholesterol drug could be new weapon against deadly blood clots
Disease control Recruiting nowThis large Phase 3 trial is testing whether adding the cholesterol-lowering drug rosuvastatin to standard blood thinners can help prevent dangerous blood clots from returning. The study will enroll 2,700 adults who recently had a major leg or lung clot, giving half the participan…
Matched conditions: POST THROMBOTIC SYNDROME
Phase: PHASE3 • Sponsor: Ottawa Hospital Research Institute • Aim: Disease control
Last updated Mar 30, 2026 14:35 UTC
-
New Clot-Busting procedure tested against standard blood thinners
Disease control Recruiting nowThis study is testing whether a new procedure to physically remove blood clots from the leg's large veins works better than just using blood-thinning medication. It aims to see if removing the clot early helps patients avoid long-term pain, swelling, and other complications. Abou…
Matched conditions: POST THROMBOTIC SYNDROME
Phase: NA • Sponsor: Inari Medical • Aim: Disease control
Last updated Mar 02, 2026 15:22 UTC